ID   DGKZ_RAT                Reviewed;         929 AA.
AC   O08560;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   02-OCT-2024, entry version 184.
DE   RecName: Full=Diacylglycerol kinase zeta {ECO:0000303|PubMed:15157668};
DE            Short=DAG kinase zeta;
DE            EC=2.7.1.107 {ECO:0000250|UniProtKB:Q13574};
DE            EC=2.7.1.93 {ECO:0000250|UniProtKB:Q13574};
DE   AltName: Full=104 kDa diacylglycerol kinase;
DE   AltName: Full=DGK-IV;
DE   AltName: Full=Diglyceride kinase zeta;
DE            Short=DGK-zeta;
GN   Name=Dgkz {ECO:0000312|RGD:70929}; Synonyms=Dagk6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RC   STRAIN=Wistar;
RX   PubMed=8855332; DOI=10.1073/pnas.93.20.11196;
RA   Goto K., Kondo H.;
RT   "A 104-kDa diacylglycerol kinase containing ankyrin-like repeats localizes
RT   in the cell nucleus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:11196-11201(1996).
RN   [2]
RP   INTERACTION WITH PIP5K1A.
RX   PubMed=15157668; DOI=10.1016/j.cellsig.2004.01.010;
RA   Luo B., Prescott S.M., Topham M.K.;
RT   "Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-
RT   kinase Ialpha by a novel mechanism.";
RL   Cell. Signal. 16:891-897(2004).
CC   -!- FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into
CC       phosphatidic acid/phosphatidate/PA and regulates the respective levels
CC       of these two bioactive lipids. Thereby, acts as a central switch
CC       between the signaling pathways activated by these second messengers
CC       with different cellular targets and opposite effects in numerous
CC       biological processes. Also plays an important role in the biosynthesis
CC       of complex lipids. Does not exhibit an acyl chain-dependent substrate
CC       specificity among diacylglycerol species. Can also phosphorylate 1-
CC       alkyl-2-acylglycerol in vitro but less efficiently and with a
CC       preference for alkylacylglycerols containing an arachidonoyl group (By
CC       similarity). The biological processes it is involved in include T cell
CC       activation since it negatively regulates T-cell receptor signaling
CC       which is in part mediated by diacylglycerol (By similarity). By
CC       generating phosphatidic acid, stimulates PIP5KIA activity which
CC       regulates actin polymerization (By similarity). Through the same
CC       mechanism could also positively regulate insulin-induced translocation
CC       of SLC2A4 to the cell membrane (By similarity). Regulates RASGRP1
CC       activity (By similarity). {ECO:0000250|UniProtKB:Q13574,
CC       ECO:0000250|UniProtKB:Q80UP3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + ATP = a 1,2-diacyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:10272, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:30616, ChEBI:CHEBI:58608,
CC         ChEBI:CHEBI:456216; EC=2.7.1.107;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10273;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-sn-glycerol + ATP = 1-O-alkyl-sn-glycero-3-phosphate
CC         + ADP + H(+); Xref=Rhea:RHEA:16937, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15850, ChEBI:CHEBI:30616, ChEBI:CHEBI:58014,
CC         ChEBI:CHEBI:456216; EC=2.7.1.93;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16938;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-2-acyl-sn-glycerol + ATP = 1-O-alkyl-2-acyl-sn-
CC         glycero-3-phosphate + ADP + H(+); Xref=Rhea:RHEA:44072,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:52595,
CC         ChEBI:CHEBI:73332, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44073;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-didecanoyl-sn-glycerol + ATP = 1,2-didecanoyl-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:43428, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:18155, ChEBI:CHEBI:30616, ChEBI:CHEBI:78227,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43429;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-ditetradecanoyl-sn-glycerol + ATP = 1,2-ditetradecanoyl-
CC         sn-glycero-3-phosphate + ADP + H(+); Xref=Rhea:RHEA:43444,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:80651,
CC         ChEBI:CHEBI:83550, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43445;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + ATP = 1-
CC         hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:43416, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:64839, ChEBI:CHEBI:75466, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43417;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40335, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:72864, ChEBI:CHEBI:77096,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40336;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + ATP = 1-
CC         octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:43424, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:74560, ChEBI:CHEBI:75468, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43425;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40323, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:75728, ChEBI:CHEBI:77091,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40324;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycerol + ATP = 1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
CC         docosahexaenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40359, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:77129, ChEBI:CHEBI:77130, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40360;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + ATP = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40327, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:74546, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40328;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycerol + ATP = 1-(9Z)-
CC         octadecenoyl-2-hexadecanoyl-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:43420, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:74551, ChEBI:CHEBI:75447, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43421;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-eicosanoyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycerol +
CC         ATP = 1-eicosanoyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:40331, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:77094, ChEBI:CHEBI:87223,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40332;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycerol + ATP =
CC         1,2-di-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphate + ADP
CC         + H(+); Xref=Rhea:RHEA:40351, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:77125, ChEBI:CHEBI:77126, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40352;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-acetyl-sn-glycerol + ATP = 1-O-hexadecyl-2-
CC         acetyl-sn-glycero-3-phosphate + ADP + H(+); Xref=Rhea:RHEA:41676,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:75936,
CC         ChEBI:CHEBI:78385, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41677;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol +
CC         ATP = 1-O-hexadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:40403, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:77184, ChEBI:CHEBI:77186,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40404;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-(9Z-octadecenoyl)-sn-glycerol + ATP = 1-O-
CC         hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40407, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:77185, ChEBI:CHEBI:77187, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40408;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-sn-glycerol + ATP = 1-O-hexadecyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:41672, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:34115, ChEBI:CHEBI:77580,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q13574};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41673;
CC         Evidence={ECO:0000250|UniProtKB:Q13574};
CC   -!- PATHWAY: Lipid metabolism; glycerolipid metabolism.
CC       {ECO:0000250|UniProtKB:Q13574}.
CC   -!- SUBUNIT: Interacts (via PDZ-binding motif) with the PDZ domain of the
CC       syntrophin SNTG1 and that of SNX27 (By similarity). Interacts with IRS1
CC       in the absence of insulin; insulin stimulation decreases this
CC       interaction (By similarity). Found in a ternary complex with IRS1 and
CC       PIP5K1A in the absence of insulin (By similarity). Interacts with
CC       PIP5K1A (PubMed:15157668). Forms a signaling complex with RASGRP1 and
CC       HRAS (By similarity). {ECO:0000250|UniProtKB:Q13574,
CC       ECO:0000250|UniProtKB:Q80UP3, ECO:0000269|PubMed:15157668}.
CC   -!- INTERACTION:
CC       O08560; Q62696: Dlg1; NbExp=4; IntAct=EBI-8570505, EBI-389325;
CC       O08560; Q63622: Dlg2; NbExp=4; IntAct=EBI-8570505, EBI-396947;
CC       O08560; Q62936: Dlg3; NbExp=4; IntAct=EBI-8570505, EBI-349596;
CC       O08560; P31016: Dlg4; NbExp=6; IntAct=EBI-8570505, EBI-375655;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8855332}. Cytoplasm,
CC       cytosol {ECO:0000250|UniProtKB:Q13574}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q13574}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:Q13574}.
CC   -!- DOMAIN: The PDZ-binding motif mediates interaction with PDZ domain-
CC       containing proteins like SNTG1 and SNX27.
CC       {ECO:0000250|UniProtKB:Q13574}.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D78588; BAA18942.1; -; mRNA.
DR   PIR; JC6124; JC6124.
DR   RefSeq; NP_112405.1; NM_031143.1.
DR   AlphaFoldDB; O08560; -.
DR   SMR; O08560; -.
DR   BioGRID; 249679; 4.
DR   IntAct; O08560; 6.
DR   MINT; O08560; -.
DR   STRING; 10116.ENSRNOP00000024280; -.
DR   iPTMnet; O08560; -.
DR   PhosphoSitePlus; O08560; -.
DR   PaxDb; 10116-ENSRNOP00000024280; -.
DR   Ensembl; ENSRNOT00000024280.5; ENSRNOP00000024280.2; ENSRNOG00000017737.7.
DR   Ensembl; ENSRNOT00055028087; ENSRNOP00055022602; ENSRNOG00055016451.
DR   Ensembl; ENSRNOT00060017946; ENSRNOP00060013951; ENSRNOG00060010508.
DR   Ensembl; ENSRNOT00065041777; ENSRNOP00065034147; ENSRNOG00065024021.
DR   GeneID; 81821; -.
DR   KEGG; rno:81821; -.
DR   UCSC; RGD:70929; rat.
DR   AGR; RGD:70929; -.
DR   CTD; 8525; -.
DR   RGD; 70929; Dgkz.
DR   eggNOG; KOG0782; Eukaryota.
DR   GeneTree; ENSGT00940000156152; -.
DR   InParanoid; O08560; -.
DR   OrthoDB; 4642163at2759; -.
DR   BRENDA; 2.7.1.107; 5301.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   UniPathway; UPA00230; -.
DR   PRO; PR:O08560; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000017737; Expressed in thymus and 19 other cell types or tissues.
DR   ExpressionAtlas; O08560; baseline and differential.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0047649; F:alkylglycerol kinase activity; IEA:RHEA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004143; F:ATP-dependent diacylglycerol kinase activity; IDA:RGD.
DR   GO; GO:0004857; F:enzyme inhibitor activity; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; ISS:UniProtKB.
DR   GO; GO:0046486; P:glycerolipid metabolic process; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0046834; P:lipid phosphorylation; ISS:UniProtKB.
DR   GO; GO:0099562; P:maintenance of postsynaptic density structure; ISO:RGD.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.
DR   CDD; cd20849; C1_DGKzeta_rpt1; 1.
DR   CDD; cd20895; C1_DGKzeta_rpt2; 1.
DR   Gene3D; 2.60.200.40; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR047485; C1_DGKzeta_rpt1.
DR   InterPro; IPR047484; C1_DGKzeta_rpt2.
DR   InterPro; IPR037607; DGK.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   PANTHER; PTHR11255; DIACYLGLYCEROL KINASE; 1.
DR   PANTHER; PTHR11255:SF43; DIACYLGLYCEROL KINASE ZETA; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00248; ANK; 2.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF111331; NAD kinase/diacylglycerol kinase-like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
DR   PROSITE; PS50146; DAGK; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; ATP-binding; Cell membrane; Cell projection; Cytoplasm; Kinase;
KW   Lipid metabolism; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..929
FT                   /note="Diacylglycerol kinase zeta"
FT                   /id="PRO_0000218470"
FT   DOMAIN          292..426
FT                   /note="DAGKc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   REPEAT          823..853
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          858..887
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         98..153
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         173..231
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          59..80
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          257..281
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          279..417
FT                   /note="Mediates interaction with RASGRP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13574"
FT   REGION          421..441
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          760..783
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           362..370
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UP3"
FT   MOTIF           925..929
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q13574"
FT   COMPBIAS        12..26
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        27..41
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         706
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13574"
FT   MOD_RES         782
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13574"
SQ   SEQUENCE   929 AA;  104009 MW;  6279872004F5F38D CRC64;
     MEPRDPSPEA RSSDSESASA SSSGSERDAD PEPDKAPRRL TKRRFPGLRL FGHRKAITKS
     GLQHLAPPPP TPGAPCGESE RQIRSTVDWS ESAAYGEHIW FETNVSGDFC YVGEQYCVAK
     MLPKSAPRRK CAACKIVVHT PCIGQLEKIN FRCKPSFRES GSRNVREPTF VRHHWVHRRR
     QDGKCRHCGK GFQQKFTFHS KEIVAISCSW CKQAYHSKVS CFMLQQIEEP CSLGVHAAVV
     IPPTWILRAR RPQNTLKASK KKKRASFKRR SSKKGPEEGR WRPFIIRPTP SPLMKPLLVF
     VNPKSGGNQG AKIIQSFLWY LNPRQVFDLS QGGPREALEM YRKVHNLRIL ACGGDGTVGW
     ILSTLDQLRL KPPPPVAILP LGTGNDLART LNWGGGYTDE PVSKILSHVE EGNVVQLDRW
     DLRAEPNPEA GPEERDDGAT DRLPLDVFNN YFSLGFDAHV TLEFHESREA NPEKFNSRFR
     NKMFYAGTAF SDFLMGSSKD LAKHIRVVCD GMDLTPKIQD LKPQCIVFLN IPRYCAGTMP
     WGHPGEHHDF EPQRHDDGYL EVIGFTMTSL AALQVGGHGE RLTQCREVLL TTAKAIPVQV
     DGEPCKLAAS RIRIALRNQA TMVQKAKRRS TAPLHSDQQP VPEQLRIQVS RVSMHDYEAL
     HYDKEQLKEA SVPLGTVVVP GDSDLELCRA HIERLQQEPD GAGAKSPMCH PLSSKWCFLD
     ATTASRFYRI DRAQEHLNYV TEIAQDEIYI LDPELLGASA RPDLPTPTSP LPASPCSPTP
     GSLQGDAALP QGEELIEAAK RNDFCKLQEL HRAGGDLMHR DHQSRTLLHH AVSTGSKEVV
     RYLLDHAPPE ILDAVEENGE TCLHQAAALG QRTICHYIVE AGASLMKTDQ QGDTPRQRAE
     KAQDTELAAY LENRQHYQMI QREDQETAV
//
